论文部分内容阅读
近年来我们用强力宁注射液与聚肌胞联合静点(治疗组)和单用强力宁静点(对照组)治疗慢性乙型肝炎,结果如下。 一、临床资料 本组病例符合1984年南宁全国肝炎会议制订的诊断标准,并经血清学检测证实为乙型肝炎患者,两组病例HBVM均有1～3项阳性。治疗组38例,男32例,女6例,年龄15～57岁(平均32.1岁),慢性迁延性肝炎、慢性活动性肝炎各19例,ALT53～1010u(正常值<30u),AST35～850u(正常值<30u),SB异常者14例,其值为24.32～～63.58#mol/L(正常值<18.7/~mol/L),TTT异常者23例,其值为8～20u(正常值<7u)。对照组20例,男19例,女1例;
In recent years, we used strong Ning injection and polyglutamine combined intravenous (treatment group) and single strong point (control group) treatment of chronic hepatitis B, the results are as follows. First, the clinical data of this group of patients in line with the 1984 Nanning National Conference on hepatitis diagnostic criteria developed and confirmed by serological tests for hepatitis B patients, HBVM in both groups were 1 to 3 were positive. There were 38 cases in the treatment group, including 32 males and 6 females, aged from 15 to 57 years (mean, 32.1 years), chronic persistent hepatitis and chronic active hepatitis, with ALT53 ~ 1010u (normal <30u) and AST35 ~ 850u (Normal value <30u), SB abnormalities in 14 cases, the value of 24.32 ~ 63.58 # mol / L (normal <18.7 / ~ mol / L), TTT abnormalities in 23 cases, the value of 8 ~ 20u Value <7u). Control group of 20 patients, 19 males and 1 female;